Author Contributions: Drs Kosiborod and Spertus had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Kosiborod, Krumholz, Spertus.
Acquisition of data: Kosiborod, Spertus.
Analysis and interpretation of data: Kosiborod, Inzucchi, Goyal, Krumholz, Masoudi, Xiao, Spertus.
Drafting of the manuscript: Kosiborod.
Critical revision of the manuscript for important intellectual content: Kosiborod, Inzucchi, Goyal, Krumholz, Masoudi, Xiao, Spertus.
Statistical analysis: Kosiborod, Xiao.
Obtained funding: Kosiborod, Spertus.
Administrative, technical, or material support: Kosiborod, Spertus.
Study supervision: Kosiborod, Spertus.
Financial Disclosures: Dr Kosiborod reported that he has served on the advisory board of Sanofi-Aventis and has received speaking honoraria from the Vascular Biology Working Group and DiaVed, Inc. Dr Inzucchi reported that he received research grant support from Lilly. Dr Krumholz reported being a consultant or a subject matter expert for VHA Inc, having research contracts with the American College of Cardiology and the Centers for Medicare & Medicaid Services, being on an advisory board for UnitedHealthcare, Alere, and Amgen, providing testimony on behalf of plaintiffs in the Vioxx trial, serving as editor-in-chief of Circulation: Cardiovascular Quality and Outcomes and Journal Watch Cardiology of the Massachusetts Medical Society, and participating in early phase translational research activities for Centegen/LifeTech. Dr Masoudi reported that he has been a member of the advisory board for Takeda Pharmaceuticals. Dr Spertus reported that he receives research grant support from Sanofi-Aventis and Lilly. Drs Goyal and Xiao did not report any financial disclosures.
Funding/Support: The research for this article was supported by the American Heart Association Career Development Award in Implementation Research awarded to Dr Kosiborod and by the Cerner Corporation.
Role of Sponsors: The Cerner Corporation facilitated the collection of the deidentified Health Facts data and reviewed the manuscript, but had no role in the design or conduct of the study; the management, analysis, or interpretation of the data; or the preparation or approval of the manuscript. The American Heart Association had no role in the study.